NCT06243328

Brief Summary

This study will compare the NPWT using the NPD to the conventional wound dressing and specifically evaluating (i) reduction of wound surface area and depth, (ii) removal of slough and formation of granulation tissue

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2024

Shorter than P25 for not_applicable

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 29, 2024

Completed
3 days until next milestone

Study Start

First participant enrolled

February 1, 2024

Completed
5 days until next milestone

First Posted

Study publicly available on registry

February 6, 2024

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2024

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2024

Completed
Last Updated

February 6, 2024

Status Verified

January 1, 2024

Enrollment Period

4 months

First QC Date

January 29, 2024

Last Update Submit

January 29, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • ulcer size

    measured for its greatest length ,depth and width with flexigrid Opsite.

    3 weeks

Study Arms (2)

conventional dressing

EXPERIMENTAL

The surface of the PU will be cleaned with normal saline and packed with sterilised gauze to cover the wound. Dressing changes will be performed once or twice daily depending on the soakage of the dressing

Device: negative wound pressure therapy

negative pressure wound therapy

EXPERIMENTAL

We will place a nonadherent contact layer, such as Xeroform between prepared wound bed and foam then applying a contact dressing with sealling using an adhesive drape. The dressing will be connected to the machine through tubing that was connected to the canister. Continuous pressure of 200 mm Hg will be applied. The dressing will be changed three times a week.

Device: negative wound pressure therapy

Interventions

nonadherent contact layer, such as Xeroform between prepared wound bed and foam then applying a contact dressing with sealling using an adhesive drape. The dressing will be connected to the machine through tubing that was connected to the canister

conventional dressingnegative pressure wound therapy

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Stages three and four PU as defined by the National Pressure Ulcer Advisory Panel (NPUAP).

You may not qualify if:

  • wound with necrotic tissue unlikely to tolerate debridement. Exposed Vessels, Nerves and or organs. Active bleeding. Ischemic limb. Opening into body cavity

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Related Publications (3)

  • Avsar P, Moore Z, Patton D. Dressings for preventing pressure ulcers: how do they work? J Wound Care. 2021 Jan 2;30(1):33-39. doi: 10.12968/jowc.2021.30.1.33.

    PMID: 33439083BACKGROUND
  • Srivastava RN, Dwivedi MK, Bhagat AK, Raj S, Agarwal R, Chandra A. A non-randomised, controlled clinical trial of an innovative device for negative pressure wound therapy of pressure ulcers in traumatic paraplegia patients. Int Wound J. 2016 Jun;13(3):343-8. doi: 10.1111/iwj.12309. Epub 2014 Jun 3.

    PMID: 24894079BACKGROUND
  • Lesiak AC, Shafritz AB. Negative-pressure wound therapy. J Hand Surg Am. 2013 Sep;38(9):1828-32. doi: 10.1016/j.jhsa.2013.04.029. Epub 2013 Jun 25. No abstract available.

    PMID: 23809469BACKGROUND

MeSH Terms

Conditions

Pressure Ulcer

Interventions

Negative-Pressure Wound Therapy

Condition Hierarchy (Ancestors)

Skin UlcerSkin DiseasesSkin and Connective Tissue Diseases

Intervention Hierarchy (Ancestors)

DrainageTherapeuticsSurgical Procedures, OperativeWound Closure Techniques

Study Officials

  • assem hussien, professor

    Assiut University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

issraa aly mohamed, resident doctor

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Masking Details
Based on determining the main outcome variable, the estimated minimum required sample size is 39 patients (13 patient in each group
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
resident doctor

Study Record Dates

First Submitted

January 29, 2024

First Posted

February 6, 2024

Study Start

February 1, 2024

Primary Completion

June 1, 2024

Study Completion

December 1, 2024

Last Updated

February 6, 2024

Record last verified: 2024-01